The fundraising will mark the biggest initial close for a first-time fund across any alternative investment strategy after SoftBank’s $100 billion Vision Fund and the China Structural Reform Fund.

Lyfebulb, the company co-founded by <strong>Dr. Karin Hehenberger PhD</strong>, with <strong>Dr. Steve Squinto</strong>, Venture partner Orbimed and <strong>Riccardo Braglia</strong>, CEO Helsinn, is about to launch an early-stage Autoimmune Disease / Diabetes Innovation Venture Fund. &nbsp;The Scientific Advisory Board is chaired by <strong>Robert Langer PhD</strong>, David H. Koch Institue, MIT.<br /> <br /> Focused on breakthrough opportunities in autoimmune, insulin-dependent diabetes and other associated autoimmune diseases. Our goals are to deliver a superior return on investment.

They may be known or referred by other names or terminologies but “Proxy Investors” have many takers in the real estate sector especially when it comes to housing loans. Still these Proxy Investors a...

Private equity firm Toro Finserv LLP, which is floated by investment and healthcare industry veteran Kapil Khandelwal, is raising its debut healthcare real estate fund, the company said in a statemen...

We are in a perverse moment in the global venture capital industry: VCs are fast coming to resemble private hedge funds, and the more money they are able to raise, the worse off startups are becoming.

After a late 2016 slump, venture capital investment into UK start-ups rises significantly in the first quarter of the new year. VC investment rises to £804m in the first quarter of the year, showing UK is still an attractive place to do business despite Brexit.

NEW YORK (Thomson Reuters Regulatory Intelligence) - Investment-fund boards of directors have a critical responsibility to be an "independent watchdog" on behalf of investors. For most U.S. retail in...

<div class="bw-release-subhead"> <p class="bwalignc"><b>Bank Receives Top Honors in U.S., Europe</b></p> </div> <div class="bw-release-timestamp"><time datetime="2017-03-01T13:59:00Z" itemprop="dateModified">March 01, 2017 08:59 AM Eastern Standard Time</time></div> <p>NEW YORK--(<span itemid="http://www.businesswire.com" itemprop="provider publisher copyrightHolder" itemscope="itemscope" itemtype="http://schema.org/Organization"><span itemprop="name"><a href="http://www.businesswire.com/" itemprop="url" rel="nofollow">BUSINESS WIRE</a></span></span>)--Citi was named Placement Agent of the Year by Private Debt Investor (PDI), a leading international publication covering the world&rsquo;s private debt markets. The designation includes two separate wins regionally in both Europe and in the Americas, which encompasses the U.S., Canada, and Latin America.<br /> <br /> The winners of the annual global PDI awards are chosen by the magazine&#39;s readership, which represents over 23,000 across the globe, with institutional investors representing the largest segment. The publication annually recognizes the best and brightest industry participants helping to shape private debt markets.</p> Citigroup Global Markets Citi Private Debt Private Equity Mezzanine Private Markets Fixed Income Direct Lending Asset Allocation Pensions Insurance Endowments Foundations Family Office PE Real Estate Infrastructure Nithin Johnson Head of Americas Peter Arnold Global Head International Fund Distribution